Upcoming Events

9th Asia Pacific Chapter Meeting of the ISPD

September 5 - 7, 2019
Nagoya, Japan

Symposium:
Friday, September 6, 2019: 2:00 PM - 3:40 PM
Nagoya Congress Center

Topics and Speakers:
  • PDOPPS: Current status of worldwide PDOPPS – Jeffrey Perl 
  • Treatment and Prevention of Peritoneal Dialysis Related Infections in PDOPPS – Neil Boudville
  • Novel Insights in PD First Policy from PDOPPS – Talerngsak Kanjanabuch
  • Expectation and Influence of PDOPPS to Japan – Kawanishi H

48th EDTNA/ERCA International Conference

September 14 - 17, 2019
Prague, Czech Republic

Symposium: Update from the DOPPS Program: Centering care around patients
Sunday, September 15, 2019: 11:00 AM - 12:30 PM
Hall A2

Topics and Speakers:
  • DOPPS: Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in haemodialysis patients - Jennie King
  • PDOPPS: Perceptions about the dialysis modality decision process among peritoneal dialysis and in-centre haemodialysis patients - Anna Marti i Monros
  • CKDopps: Coping with kidney disease - qualitative findings from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study - Michel Roden
  • Patient perspectives on the choice of dialysis modality: Results from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study -  Marisa Pegoraro

French Society of Dialysis and Transplantation (SFNDT)

October 1 - 4, 2019
Nancy, France

Topic and Speaker:
The DOPPS Odyssey: Reducing unwarranted practice variation really does improve dialysis patient outcomes! – Bruce Robinson
Wednesday, October 2, 2019: 10:00 AM - 10:45 AM

Past Events

Japanese Society for Dialysis Therapy (JSDT)

June 28 - 30, 2019
Yokohama, Japan
DOPPS Symposium
June 29, 2019, presentation begins at 4:20 p.m.

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 13-16, 2019
Budapest, Hungary

Poster Presentations
Friday, June 14
  • Kt/V Achievement and Mortality in Hemodialysis Patients in the Gulf Cooperation Council (GCC) Countries: Results from DOPPS (2012-2018) (Poster #FP530)
Saturday, June 15
  • Impact of long term serum phosphorus control on cardiovascular mortality using a 6-month area under the curve approach in the DOPPS (Poster #SP603)
  • Hemoglobin, Patient-Reported Physical Activity, and Risk of Death and CKD Progression in Stage 3-5 CKD Patients: Results from CKDopps (Poster #SP329)

ISN World Congress of Nephrology 2019

April 12 - 15, 2019
Melbourne, Australia
Symposium: Listening to patients to improve outcomes for persons nearing kidney failure or on dialysis
Friday, April 12, 2019: 2:00 PM - 4:00 PM
Session Chairs: Simon Davies and Allison Tong
Topics and Speakers:
  • Shared decision making regarding treatment options for kidney failure – Roberto Pecoits-Filho
  • Advantages and disadvantages of peritoneal dialysis: what do patients tell us? – Angela Yee Moon Wang
  • Expanding options for frail persons with kidney failure: assisted home dialysis, dialysis avoidance, and dialysis withdrawal – Norio Hanafusa
  • Empowering dialysis patients: Understanding and improving patient-provider connections – Lalita Subramanian

American Society of Nephrology Kidney Week 2018

October 23 - 28, 2018
San Diego, CA
Booth #2236

Clinical Session with DOPPS Program Talks
Transitioning Patients to Dialysis Care: Caring for Patients in a Vulnerable Time Period
Saturday, October 27, 2018
2:00 PM – 4:00 PM
Location: 6B

Moderators: Maria V. DeVita and Eric L. Wallace

Topics and Speakers:

  • "Be Prepared...": Offering Real Choice and Adequate Preparation for Patients Facing Kidney Failure (CKDopps) - Ziad Massy
  • Education During Transitions to ESRD - Matthew J. Oliver
  • "Steady as She Goes...": Limiting Complications and Improving Survival in the Early Dialysis Period (DOPPS) - Bruce M. Robinson
  • A Novel Transition Program in Action - Brendan T. Bowman

Oral Presentations

  • International Comparisons of Mortality Among Hemodialysis Patients in the DOPPS (#TH-OR092)

Poster Presentations

  • Associations of Anemia with Quality of Life in CKD Stage 3-5 Patients: Results from CKDopps in the US and Brazil (#TH-PO266)
  • Cinacalcet Prescription Across US Hemodialysis Facilities: Facility Variability and Predictors (#SA-PO666)
  • The impact of newly developed inflammation, characterized by rise in C-reactive protein, on anemia management practices in hemodialysis patients: A before-after design in the DOPPS (#TH-PO252)
  • Beta-2 Microglobulin Levels and All-Cause Mortality: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (#FR-PO825)
  • Estimating the Fraction of First-year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS (#FR-PO801)
  • Differing Attitudes towards peritoneal dialysis (PD) among PD and hemodialysis (HD) Medical Directors (#TH-PO372)
  • Regional Variation in Peritoneal Dialysis (PD) Time on Therapy (ToT): Results from The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (#TH-PO371)

47th EDTNA/ERCA International Conference

September 15 - 18, 2018
Genoa, Italy
Booth #21

Symposium: Update from the DOPPS Program: Improving care, outcomes, and the patient experience
Sunday, September 16, 2018: 12:45 PM - 1:45 PM
Grecale Room

Topics and Speakers:

  • DOPPS: Key hemodialysis practice changes and their impact – Loreto Gesualdo
  • PDOPPS: New insights into optimal PD practice – Jen King
  • CKDopps: Opportunities to improve care now for patients with advanced CKD – Solène Laville
  • Empowering patients: Understanding and improving patient-provider connections – Marisa Pegoraro

Japanese Society for Dialysis Therapy (JSDT)

June 28 - July 1, 2018
Kobe, Japan

DOPPS Symposium: Sunday, July 1 at 8:20 a.m.

Chairpersons: Masafumi Fukagawa and Masaomi Nangaku
Speakers:

  • Masaaki Inaba
  • Kousaku Nitta
  • Bruce Robinson
  • Junichi Hosino
  • Suguru Yamamoto
  • Tadao Akizawa

PDOPPS Symposium: Sunday, July 1 at 10:20 a.m.

Chairpersons: Hideki Kawanishi and Bruce Robinson
Speakers:

  • Bruce Robinson
  • Hideki Kawanishi
  • Yasuhiko Ito
  • Mizuya Fukasawa
  • Tadashi Tomo

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

May 24-27, 2018
Copenhagen, Denmark
Booth #2.162

DOPPS Program Clinical Symposium
The sweet truth: Optimizing care in advanced CKD and dialysis with a focus on diabetic patients
Friday, May 25, 11:45 a.m. – 1:15 p.m., Room C1-M1-2

Chairpersons: Helmut Reichel and Bruce Robinson

Topics and Speakers:

  • DOPPS Program: The burden of diabetes in advanced CKD and dialysis - Bruce Robinson
  • PDOPPS: Variation in the PD prescription, glucose exposure, and outcomes - Mark Lambie
  • DOPPS: Hepatitis C in HD patients - prevalence trends over 20 years, outcomes, and use of newer treatments - Michel Jadoul
  • CKDopps: Diabetes treatment, control, and hypoglycemia in patients with advanced CKD - Benedicte Stengel
  • EURODOPPS: Outcomes according to different strategies of HbA1c use among diabetic HD patients - Ionut Nistor

Poster Presentations

Friday, May 25

  • Changes in practice patterns in Japan from before to after JSDT 2013 guidelines on hemodialysis prescriptions (Poster #FP638)
  • CKD progression in Germany (Poster #FP346)
  • International variation in MBD measurement, vitamin D prescription, and phosphate binder prescription patterns among patients with chronic kidney disease (Poster #FP386)
  • Patient-reported disadvantages of peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #FP483)
  • Satisfaction, convenience, and difficulties in taking phosphate binders: Relationships with phosphate binder adherence in hemodialysis patients in the DOPPS (Poster #FP610)

Saturday, May 26

  • Association between dipeptidyl peptidase-4 inhibitor prescription and erythropoiesis stimulating agent hyporesponsiveness in hemodialysis patients with diabetes mellitus (Poster #SP345)
  • Indoxyl sulfate and mortality in hemodialysis patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS) (Poster #SP617)
  • Is low hemoglobin at hemodialysis initiation associated with first-year survival among patients treated to target levels soon after dialysis start? (Poster #SP340)
  • Remote management for peritoneal dialysis: Perspectives on effects on care (Poster #SP502)
  • The association of functional status with mortality and dialysis modality change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #SP532)

National Kidney Foundation 2018 Spring Clinical Meetings

April 10-14, 2018
Austin, TX


American Society of Nephrology Kidney Week 2017

October 31 - November 5, 2017
New Orleans, LA

Oral Presentations

  • Are RAASi underused in moderate to advanced CKD? Early findings from CKDopps
  • Contemporary anemia management in peritoneal dialysis patients: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)  
  • Low serum potassium is associated with indicators of under-nutrition and reduced residual kidney function: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
Poster Presentations
    
Residual urine volume in hemodialysis patients: International trends, predictors and outcomes in the DOPPS Functional status among patients receiving peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) Patient-reported advantages and disadvantages of peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
Mineral bone disorder management in dialysis patients: Comparing PTH control practices in Japan with Europe and North America in the DOPPS Evaluation of gender differences in the association between hemoglobin and survival among hemodialysis patients in the JDOPPS FGF23 and mortality in a large cohort of prevalent hemodialysis patients: Results from the JDOPPS
  • Current nephrology practices for slowing CKD progression - The Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps)
  • International serum 25-OH-vitamin D measurement, levels, and treatment among patients with chronic kidney disease (CKD) in everyday nephrology practice: Results from CKDopps
  • Mineral and bone disorder (MBD) markers and management over the first 5 years after dialysis start: Results from the DOPPS
  • Engaging stakeholders in protocol development for qualitative research on remote management for peritoneal dialysis

46th EDTNA/ERCA International Conference

September 9 -12, 2017
Krakow, Poland

Symposium: The DOPPS Program Continues to Grow
Sunday, September 10, 2017: 12:45 PM - 1:45 PM
Theater Hall

Topics and Speakers:

  • Key hemodialysis practice changes and their impact – Andrzej Wiecek
  • PDOPPS: Identifying optimal practices in PD – Jen King
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis – Elodie Speyer
  • “Ask your patients and do something about it”: The patient perspective in DOPPS – Jeanette Wallin

Japanese Society for Dialysis Therapy (JSDT)

June 16-18, 2017

Yokohama, Japan

DOPPS/ PDOPPS Symposium

June 18, 2017

DOPPS Presentation begins at 8:20 a.m.

PDOPPS presentation begins at 10:20 a.m.


European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 3-6, 2017

Madrid, Spain

Symposium: Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program

June 5, 2017 at 3:15 p.m. 

Session number S 37, Hall 10

Topics and Speakers:

  • The DOPPS Program: invitation to collaborators - Hugh Rayner
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis - Helmut Reichel
  • DOPPS: Impact of clinical practices on early mortality among HD patients - Takeshi Hasegawa
  • PDOPPS: Predictors of early successful PD use - Martin Wilkie
  • Recent results from the EURODOPPS - Ayesha Sajjad

Free Communications

Sunday, June 4

  • Cinacalcet discontinuation and its predictors in hemodialysis patients: Results from 7 European countries (#SO034). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Regional variation in mineral and bone disorder (MBD) markers and treatment at dialysis start: Results from the DOPPS (#SO032). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Dialysate calcium concentration <3.0mEq/L is not associated with improved outcomes in the Japan DOPPS (#SO061). Session: Epidemiology in dialysis – 2 (5:00-6:30 p.m.)

Monday, June 5

  • International differences in time from arteriovenous fistula (AVF) creation until becoming catheter-free among HD patients using a catheter at time of AVF creation: Results from the DOPPS (#MO047). Session: Vascular Access (3:15 p.m.)
  • Early Peritoneal Dialysis Attrition: Preliminary Results from The Peritoneal DOPPS (#MO061). Session: Peritoneal dialysis (5:00 p.m.)

Posters

Sunday, June 4, 9:30-10:45 a.m.

  • Associations of coping strategies with quality of life, depression and mortality among hemodialysis patients in the DOPPS (#SP623)
  • Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International variability and clinical predictors (#SP498)
  • International variation in PD catheter practices: Preliminary results from the Peritoneal DOPPS (#SP503)
  • Renin-angiotensin-aldosterone system inhibitors (RAASi) and clinical outcomes in hemodialysis patients: Results from the DOPPS (#SP551)
  • Treatments of mineral and bone disorder may be under-utilized in CKD patients (#SP369)

Monday, June 5, 9:30-10:45 a.m.

  • Prevalence of hyperkalemia in DOPPS: A real-world, international cohort of hemodialysis patients (#MP371)
  • Renin-angiotensin-aldosterone system inhibitor prescription patterns in hemodialysis patients: Results from the International DOPPS (#MP385)
  • Variation in Renin Angiotensin Aldosterone System Inhibitor (RAASi) prescription internationally and across CKD stages (#MP409)
  • Regional Differences in the Associations between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the DOPPS: A Call for Quality Assurance? (#MP704)

American Society of Nephrology Kidney Week 2016

November 15-20, 2016
Chicago, IL

Featured Posters

          
International variation in dialysis discontinuation: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract #TH-PO1108)  Association between diuretic use and residual kidney function in peritoneal dialysis patients: International comparison from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #SA-PO1102)
 Also Presented
  • Prevalence and dosing patterns of ESAs used in 9 European countries: DOPPS (Abstract #SA-PO1007)
  • Hyperkalemia and prescription of antihypertensive medications: Early findings from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #SA-PO796)
  • International variations in the frequency of the types of patient-physician contact for CKD patients: Early findings from CKDopps (Abstract #SA-PO927)
  • Geographical and seasonal patterns of blood pressure in hemodialysis patients: A EURODOPPS study (Abstract #TH-PO990)
  •  Higher phosphorus is associated with lower hemoglobin in CKD stages 3-5: Early results from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #FR-PO789)
  •  Facility use of low dialysate temperature for prevention of intra-dialytic hypotension is associated with lower cardiovascular mortality in the DOPPS (Abstract #FR-PO938)